[{"_1":2,"_100":-5,"_101":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,76,88],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_53":54,"_55":56,"_57":58,"_59":60,"_61":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},"mediaId",6284653,"mediaKeyId","2577175-4811ee0155538374767aacd64d2f3eed","parentId",2577175,"title","Committee backs amendment to ensure Medicaid covers continuous glucose monitors for gestational diabetes (House Bill 352, LC520828S)","audioSeconds",363,"startMs",2216000,"endMs",2579000,"viewUrl","/Search/View?dp=1&key=2577175-4811ee0155538374767aacd64d2f3eed&start=2216&end=2579","thumbnailUrl","https://assets.pipeline.soar.com/2577175-4811ee0155538374767aacd64d2f3eed/thumbnail_2216000.jpg","articleUrl","/articles/6284653/Georgia/Committee-backs-amendment-to-ensure-Medicaid-covers-continuous-glucose-monitors-for-gestational-diabetes-House-Bill-352-LC520828S","mediaUrl","https://secure.pipeline.soar.com/6284653-16045f05dc546c737df0e99bb11a3a32/orig.mp4?Expires=1771195148&Signature=Y4MayijBV9NDNm8EyVEF7dFMirVluoOFH-ffgZIYBVFcyHNuFVfEDMprWqlYCEDcQqMKLOUFQZfQ0iFSKRFUQot6ck40Tn6PBpOyr1I6P5lUkWMeM1eYr3YdexE0JYfDRVNRhR9~lzaMVBHoAm3rNCCzZbM9GvuMQMFExj3S0hE19vwH4KTbFnfMYC5yANd3v7IDpcsVFljd3VsBV4tX5KXbPQIJnAl5Exmt2QAmoHXxcsLEh9tcl-WVskrYkJ-vOpZUrlhSzrQ7LpkqmxzMCyUsEy7HGkpyD4o1aDLAnMivWKkDis6xvc~5jZH7u1GB6q3TLXdYV~GzJOulZKOGXw__&Key-Pair-Id=KUT5TJCACFTXG","author","Georgia State Legislature","date","2025-03-10T00:00:00Z","article","The committee unanimously passed an amendment to House Bill 352 (LC 520828S) Thursday that explicitly adds gestational diabetes to the list of covered indications under Medicaid for continuous glucose monitors (CGMs) and updates the statutory effective date.

\"It's a simple but significant amendment...the amendment ensures that Medicaid will cover continuous glucose monitors for pregnant women diagnosed with, with diabetes, and we've added the word gestational diabetes,\" the bill's sponsor said in presenting the substitute language. The sponsor said the substitute also updates a statutory date to 2025 and restores a provision about a threshold for insulin administration in one clause.

A committee member who said the device changed his life described the CGM as \"a button\" worn on the arm that sends real‑time glucose readings to a phone and said his A1C dropped \"from 10 down to 6.5.\" That testimonial framed the policy argument for making CGMs available when prescribed for gestational diabetes to reduce risks such as preterm birth, high birth weight and future development of type 2 diabetes.

Brandy Sullivan of the Department of Community Health told the committee the legislature passed a law last year mandating coverage of CGMs and that the new language clarifies coverage to include gestational diabetes and notes the change is effective July 1, 2025. \"We did pass a bill last year, that mandated coverage of these devices...so I think that's just being updated to say that this new requirement that gestational diabetes be an included disease state for coverage is effective 07/01/2025,\" Sullivan said.

A motion to pass LC520828S was made from the floor and the committee approved the substitute by unanimous voice vote. Committee discussion noted the substitute was recommended by the Department of Community Health and that the change was intended to fill an unintended gap in coverage for pregnant people diagnosed with gestational diabetes.","mediaType","Video","parentTitle","03/10/2025 Senate Committee on Health and Human Services","oneSentenceSummary","Lawmakers unanimously advanced an amendment to a previously enacted law to explicitly require Medicaid coverage of continuous glucose monitors for pregnant women with gestational diabetes and to update the effective date to July 1, 2025.","taxTitle","2025 Legislature Georgia , Georgia","taxId",77688,"location","Georgia","headline","","shortSummary",{"_33":77,"_35":36,"_37":38,"_39":78,"_41":79,"_43":80,"_45":81,"_47":82,"_49":83,"_51":84,"_53":85,"_55":56,"_57":58,"_59":86,"_61":62,"_63":64,"_65":87,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6284659,"Committee advances bill to create regional perinatal advisory committee; expands data access for maternal‑mortality review",398,1385000,1783000,"/Search/View?dp=1&key=2577175-4811ee0155538374767aacd64d2f3eed&start=1385&end=1783","https://assets.pipeline.soar.com/2577175-4811ee0155538374767aacd64d2f3eed/thumbnail_1385000.jpg","/articles/6284659/Georgia/Committee-advances-bill-to-create-regional-perinatal-advisory-committee-expands-data-access-for-maternalmortality-review","https://secure.pipeline.soar.com/6284659-ccdb5337be3181cd0a3b20274bdfdce1/orig.mp4?Expires=1771195148&Signature=mEg0QeEvIfaRgzFl7MAD4nuqZDdqbX1RhuO8RpDSG7K5AE1LcuGETGZcA2BjT50TbMEY~ZlTh8UvLwDmUm11IFy1mWScP459LByhDOKMMYvhEKWlQraQ-C5teh0MHHR88HfEPDCDunPoi7hu2Sf1j-cKtV1EBaeDHw1TivzC0aUiMmv7SEe1CDtojPDBh4BF2ZOemKMg8GSDNlY6xvCrweJ1l7Ccr5P5EdiG7rP9F1x3RZ6s2Frk4yodbcXTu~XD1bXA2J6fGVpZQSPI8NX~Ybk8TFApLm9rOTKvg7pXTHY8euVpxIIoXxLCpNIYGA2bC2ByrB9yUVjjBDi3V8To9g__&Key-Pair-Id=KUT5TJCACFTXG","The committee unanimously passed House Bill 89 on Thursday, establishing a regional perinatal center advisory committee to coordinate services among Georgia's six regional perinatal centers and to advise whether an additional center is needed.

\"What House Bill 89 does is, very important to our state. It sets up a regional perinatal center advisory committee,\" the bill's sponsor said as the committee considered the measure. The sponsor said the state currently has six centers and that an additional center may be necessary in the Atlanta region because it covers a large number of counties.

Megan Andrews, assistant commissioner for policy at the Georgia Department of Public Health, described the advisory committee as an output of a recent meeting among the department, regional perinatal centers and the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD). \"This is an output from that meeting where we were working with the regional perinatal centers to develop priorities for this session,\" Andrews said. She told the committee the advisory group will \"be looking at the hospital‑based system of care\" and recommend whether to add another regional perinatal center and where it should be located.

The bill also addresses the state maternal mortality review process. The sponsor and Andrews said the Maternal Mortality Review Committee (MMRC) will continue its case‑by‑case review of maternal deaths, but the advisory committee and MMRC roles will remain distinct: the MMRC conducts in‑depth reviews of deaths while the new advisory committee will focus on hospital‑based systems of care.

Committee members discussed barriers to obtaining psychiatric and behavioral‑health records for mortality reviews. \"There's stricter confidentiality provisions around access to mental‑health records,\" Andrews said, describing why mental‑health providers have sometimes declined to share records with reviewers. The bill makes clear that the review committee should have access to psychiatric records needed to conduct maternal‑mortality reviews and to recommend improvements.

A motion to pass was made and recorded in the transcript by Senator Mangum and seconded by Chairman Brass; the committee approved the bill by unanimous voice vote. No amendments were recorded in the committee discussion.","Lawmakers advanced a bill to create a regional perinatal center advisory committee and clarified access to mental‑health records for the state's Maternal Mortality Review Committee; the measure passed unanimously in committee.",{"_33":89,"_35":36,"_37":38,"_39":90,"_41":91,"_43":92,"_45":93,"_47":94,"_49":95,"_51":96,"_53":97,"_55":56,"_57":58,"_59":98,"_61":62,"_63":64,"_65":99,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6284664,"Committee gives unanimous due pass to annual controlled-substances schedule update (House Bill 473)",169,1151000,1320000,"/Search/View?dp=1&key=2577175-4811ee0155538374767aacd64d2f3eed&start=1151&end=1320","https://assets.pipeline.soar.com/2577175-4811ee0155538374767aacd64d2f3eed/thumbnail_1151000.jpg","/articles/6284664/Georgia/Committee-gives-unanimous-due-pass-to-annual-controlled-substances-schedule-update-House-Bill-473","https://secure.pipeline.soar.com/6284664-e80777b84663de7456743d93f39410c2/orig.mp4?Expires=1771195148&Signature=KStO~UVuznl6DgpU5SstysR7GKeGuwh-hPYdQoii374-bGTzTuGWDPk2TaeWHmL6ki~I4nol6DSeKaXYGfERvO1g-L~xPTq5xQ7XHGcG7FO6q4TRiEBmkgZWL9XhJAVQ1vLU4f3tXlNE6idjJuGi0N3sLYLxtWfGU6DNS3i5ceZ6eTdpGBUI04ce4iDEftqEKlxiVUlXBEZ0Z6z~eEca0Fipl4uPmMyN1tth~gRBL8uRjxV-9z5Fq~xrMipf04w16IAq56tEKHUDB7LvJqyxgfDtnWW7KZm1zfRmDrBwguvEs0TGj~R-Ca7pJ8~KzntGB0nZF0gVDl8OAlydb-k3GQ__&Key-Pair-Id=KUT5TJCACFTXG","The committee unanimously gave a due pass Thursday to House Bill 473, the annual update to Georgia's controlled‑substances schedule that adds several newly identified designer and synthetic drugs.

The measure adds an opioid designer drug, a synthetic 'mushroom' compound, ethylphenidate and a sports‑doping drug to the list of controlled substances, with several other prescription drugs updated or moved as part of the annual review. \"This is our annual update for controlled substances and for regular drugs that are just our prescription items,\" Chairman Stevens told the committee as he introduced the bill.

The bill classifies the first four listed substances as Schedule I — \"drugs that are highly addictive and have no medical use,\" Stevens said during the presentation, noting that ethylphenidate is chemically related to methylphenidate (Ritalin) but \"has no medical use\" and therefore is treated differently under the schedule.

A motion for a due pass was moved and seconded during the meeting; the committee chair called the question and the measure passed unanimously. No amendments or changes to the text were recorded in the committee discussion.

The scheduling update is presented each year to capture newly synthesized compounds and analogs that prosecutors and enforcement agencies may encounter; the chair described the listing of chemically rearranged variants as a way \"they know how to go prosecute somebody if they've created a a bad drug.\" The committee did not record a roll‑call vote count in the transcript; the chair announced the motion \"passes unanimously.\"","The committee unanimously gave a due pass to House Bill 473, an annual update that adds several designer and synthetic drugs to the state's controlled-substances schedule, including ethylphenidate and a named designer opioid and synthetic 'mushroom' compound.","actionData","errors"]

Article not found

Committee backs amendment to ensure Medicaid covers continuous glucose monitors for gestational diabetes (House Bill 352, LC520828S)

Committee advances bill to create regional perinatal advisory committee; expands data access for maternal‑mortality review

Committee gives unanimous due pass to annual controlled-substances schedule update (House Bill 473)